White House denies Trump accessed unauthorized weight-loss drug

The White House has strongly denied allegations that President Donald Trump received access to an unauthorized weight-loss medication. The reports, published by a specialized health news outlet, suggested that a pharmaceutical company and the FDA had permitted access to an experimental drug via a "compassionate use" program.

This program allows patients with immediately life-threatening medical conditions to access experimental treatments. The health publication reportedly reached out to the White House for confirmation regarding the request for the president but did not receive a direct response at the time. However, the White House has since refuted the claims.

Kush Desai, the deputy press secretary, dismissed the report's validity and criticized the author, Lizzy Lawrence, labeling her a "gossip writer." Desai's comments cast doubt on the credibility of the accusations leveled against Trump.

This denial comes after a medical report released by the White House in May, which stated that President Trump is in "excellent health." That report attributed any weight loss to changes in his diet and increased physical activity, concluding that he is fully fit to serve as President.

“

gossip writer